Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, ...
Shares of Replimune Group are rising Monday after the clinical stage biotechnology company shared an important regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback